Association between neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and survival in undifferentiated pleomorphic sarcoma (NLR, PLR, and overall survival in UPS)

•Cancer-related inflammation has been shown to be a driver of tumor growth and progression.•NLR and PLR are inflammatory biomarkers that have been shown to have prognostic significance in various malignancies.•High NLR and PLR were not independent predictors of survival in patients with undifferentiated pleomorphic sarcoma.•High NLR and PLR were associated with known poor prognostic factors, including larger tumor size and higher grade.•NLR and PLR may allow for identification of patients with poorer prognoses who may benefit from multimodal treatment.